Injections Start for First Japan-made COVID Vaccine, Targeting XBB 1.5 Variant
12:40 JST, December 14, 2023
TOKYO — Shots of the first Japan-made vaccine for the novel coronavirus are finally being administered, nearly four years after the start of the pandemic.
The vaccine, developed by Daiichi Sankyo Co. and targeting the omicron XBB 1.5 variant, uses messenger RNA like the shots made by Pfizer Inc. and Moderna Inc. in the United States, which are also widely used in Japan.
Production and sale of the vaccine for the virus’ original strain was approved by the Health, Labor and Welfare Ministry in August. In September, the XBB variant shot was also approved, and the health ministry contracted with Daiichi Sankyo to purchase 1.4 million doses. The doses will be used for booster shots for those age 12 and older.
"Society" POPULAR ARTICLE
-
Shinkansen Services Suspended After Man ‘Searches for Phone’ on Tracks; Disruption Affects About 14,000 Passengers
-
U.S. 7th Fleet officer Arrested on Suspicion of Stealing Sushi, Sashimi, Chicken at Kanagawa Shopping Mall; Suspect Caught Mid-Meal
-
JAL Airplane Experiences Radio Malfunction During Flight, Lands Safely By Relying on Light Signals
-
Cherry tree falls on man on Sanneizaka steps leading to famous Kiyomizu Temple in Kyoto
-
Earthquake in Western Japan a Reminder to Be Ready for the Big One; 14% of People Have Made No Preparations, Survey Says
JN ACCESS RANKING
- China Mutes Memorialization of Reformer Hu Yaobang; Memories Could Spark Critique of Xi Administration
- Shinkansen Services Suspended After Man ‘Searches for Phone’ on Tracks; Disruption Affects About 14,000 Passengers
- U.S. 7th Fleet officer Arrested on Suspicion of Stealing Sushi, Sashimi, Chicken at Kanagawa Shopping Mall; Suspect Caught Mid-Meal
- UNRWA Director Describes Catastrophic Destruction in Gaza; Says Relief Trucks Robbed, ‘People’s Hearts Destroyed’
- JAL Airplane Experiences Radio Malfunction During Flight, Lands Safely By Relying on Light Signals